Scott Kuduk

Person

Harleysville, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted aminopyridine compounds as EGFR inhibitors
- Patent number 11,981,658
- Issue date May 14, 2024
- Yuhan Corporation
- Byoungmoon Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminopyridine compounds as EGFR inhibitors
- Patent number 11,945,798
- Issue date Apr 2, 2024
- Yuhan Corporation
- Hyunjoo Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydroorotate dehydrogenase inhibitors
- Patent number 11,753,393
- Issue date Sep 12, 2023
- Janssen Biotech, Inc.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydroorotate dehydrogenase inhibitors
- Patent number 11,505,536
- Issue date Nov 22, 2022
- Janssen Biotech, Inc.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazepinone derivatives and methods of treating hepatitis B infe...
- Patent number 10,987,359
- Issue date Apr 27, 2021
- Novira Therapeutics, Inc.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazepinone derivatives and their use in the treatment of hepatitis...
- Patent number 10,975,077
- Issue date Apr 13, 2021
- Novira Therapeutics, Inc.
- Scott Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives and methods of treating hepatitis B infections
- Patent number 10,556,904
- Issue date Feb 11, 2020
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives and methods of treating hepatitis B infections
- Patent number 10,544,141
- Issue date Jan 28, 2020
- Novira Therapeutics, Inc.
- George D. Hartman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Azocane and azonane derivatives and methods of treating hepatitis B...
- Patent number 10,537,580
- Issue date Jan 21, 2020
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives and methods of treating hepatitis B infections
- Patent number 10,538,519
- Issue date Jan 21, 2020
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heteroaryl derivatives as orexin receptor antagonists
- Patent number 10,526,336
- Issue date Jan 7, 2020
- Merck, Sharp & Dohme Corp.
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxazole orexin receptor antagonists
- Patent number 10,435,398
- Issue date Oct 8, 2019
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azepane derivatives and methods of treating hepatitis B infections
- Patent number 10,392,349
- Issue date Aug 27, 2019
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine oxadiazole and thiadiazole orexin receptor antagonists
- Patent number 10,308,645
- Issue date Jun 4, 2019
- Merck Sharp & Dohme Corp.
- Nigel Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl orexin receptor antagonists
- Patent number 10,239,838
- Issue date Mar 26, 2019
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole orexin receptor antagonists
- Patent number 10,227,336
- Issue date Mar 12, 2019
- Merck Sharp & Dohme Corp.
- Nigel Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxmethyl piperidine orexin receptor antagonists
- Patent number 10,214,535
- Issue date Feb 26, 2019
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives and methods of treating hepatitis B infections
- Patent number 10,189,835
- Issue date Jan 29, 2019
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amidoethyl azole orexin receptor antagonists
- Patent number 10,155,750
- Issue date Dec 18, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolidine orexin receptor antagonists
- Patent number 10,150,751
- Issue date Dec 11, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives and methods of treating hepatitis B infections
- Patent number 10,093,669
- Issue date Oct 9, 2018
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives and methods of treating hepatitis B infections
- Patent number 10,077,264
- Issue date Sep 18, 2018
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine isoxazole and isothiazole orexin receptor antagonists
- Patent number 10,017,504
- Issue date Jul 10, 2018
- Merck Sharp & Dohme Corp.
- Nigel Liverton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole, triazole and tetrazole orexin receptor antagonists
- Patent number 10,010,539
- Issue date Jul 3, 2018
- Merck Sharp & Dohme Corp.
- Nigel Liverton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ethyldiamine orexin receptor antagonists
- Patent number 10,011,595
- Issue date Jul 3, 2018
- Merck Sharp & Dohme Corp.
- Ronald M. Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methyl diazepane orexin receptor antagonists
- Patent number 10,000,499
- Issue date Jun 19, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged diazepane orexin receptor antagonists
- Patent number 9,994,570
- Issue date Jun 12, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5,5-bicyclic oxazole orexin receptor antagonists
- Patent number 9,987,255
- Issue date Jun 5, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-pyridyloxy-3-ester-4-ether orexin receptor antagonists
- Patent number 9,975,876
- Issue date May 22, 2018
- Merck Sharp & Dohme Corp.
- Scott D. Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists
- Patent number 9,938,276
- Issue date Apr 10, 2018
- Merck Sharp & Dohme Corp.
- Ronald M. Kim
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES
- Publication number 20240279227
- Publication date Aug 22, 2024
- Janssen Sciences Ireland Unlimited Company
- Chunliang LU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLUORINATED QUINOLINE, QUINOXALINE AND BENZO[B][1,4]OXAZINE DERIVAT...
- Publication number 20240166622
- Publication date May 23, 2024
- JANSSEN BIOTECH, INC.
- Justin Cisar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS
- Publication number 20240158414
- Publication date May 16, 2024
- JANSSEN BIOTECH, INC.
- Justin Cisar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS
- Publication number 20230086884
- Publication date Mar 23, 2023
- Yuhan Corporation
- Byoungmoon LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-MEMBERED HETEROARYL-CONTAINING AMINOPYRIDINE COMPOUNDS AS EGFR IN...
- Publication number 20230085912
- Publication date Mar 23, 2023
- Yuhan Corporation
- Byoungmoon LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS
- Publication number 20230086795
- Publication date Mar 23, 2023
- Yuhan Corporation
- Hyunjoo LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLUORINATED QUINOLINE AND QUINOXALINE DERIVATIVES AS DIHYDROOROTATE...
- Publication number 20230037448
- Publication date Feb 9, 2023
- JANSSEN BIOTECH, INC.
- Justin Cisar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES
- Publication number 20220348592
- Publication date Nov 3, 2022
- Janssen Sciences Ireland Unlimited Company
- Sandrine Celine GROSSE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC DERIVATIVES AS ANTIVIRAL AGENTS
- Publication number 20220323455
- Publication date Oct 13, 2022
- Janssen Sciences Ireland Unlimited Company
- Scott D. KUDUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED UREA DIHYDROOROTATE DEHYDROGENASE INHIBITORS
- Publication number 20220298107
- Publication date Sep 22, 2022
- JANSSEN BIOTECH, INC.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIHYDROOROTATE DEHYDROGENASE INHIBITORS
- Publication number 20220298137
- Publication date Sep 22, 2022
- JANSSEN BIOTECH, INC.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZEPINES AS HBV CAPSID ASSEMBLY MODULATORS
- Publication number 20220251114
- Publication date Aug 11, 2022
- Janssen Sciences Ireland Unlimited Company
- Scott D. KUDUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROCYCLE DERIVATIVES
- Publication number 20220242879
- Publication date Aug 4, 2022
- Janssen Sciences Ireland Unlimited Company
- Scott D. KUDUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DI-FLUORO AZEPANES AS HBV CAPSID ASSEMBLY MODULATORS
- Publication number 20220235051
- Publication date Jul 28, 2022
- Janssen Sciences Ireland Unlimited Company
- Scott D. KUDUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZEPINONE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS
- Publication number 20220213102
- Publication date Jul 7, 2022
- Janssen Sciences Ireland Unlimited Company
- Scott D. KUDUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS
- Publication number 20220153754
- Publication date May 19, 2022
- Scott D. KUDUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH H...
- Publication number 20220135590
- Publication date May 5, 2022
- Janssen Science Ireland Unlimited Company
- Scott KUDUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIHYDROOROTATE DEHYDROGENASE INHIBITORS
- Publication number 20220089568
- Publication date Mar 24, 2022
- JANSSEN BIOTECH, INC.
- Justin Cisar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIHYDROOROTATE DEHYDROGENASE INHIBITORS
- Publication number 20220081422
- Publication date Mar 17, 2022
- JANSSEN BIOTECH, INC.
- Justin Cisar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV IN...
- Publication number 20220064147
- Publication date Mar 3, 2022
- MERCK SHARP & DOHME CORP.
- Antonella Converso
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZEPINONE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFE...
- Publication number 20210252014
- Publication date Aug 19, 2021
- Novira Therapeutics, Inc.
- Scott Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS...
- Publication number 20210188849
- Publication date Jun 24, 2021
- Novira Therapeutics, Inc.
- Scott Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIHYDROOROTATE DEHYDROGENASE INHIBITORS
- Publication number 20200331881
- Publication date Oct 22, 2020
- JANSSEN BIOTECH, INC.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZEPINONE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFE...
- Publication number 20200197408
- Publication date Jun 25, 2020
- Novira Therapeutics, Inc.
- Scott Kuduk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Derivatives And Methods Of Treating Hepatitis B Infections
- Publication number 20200181142
- Publication date Jun 11, 2020
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS...
- Publication number 20200181144
- Publication date Jun 11, 2020
- Novira Therapeutics, Inc.
- Scott Kuduk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOLIC RESTRICTION IN CELL-BASED ASSAYS
- Publication number 20190234940
- Publication date Aug 1, 2019
- Novira Therapeutics, Inc.
- Man Iu LAM
- G01 - MEASURING TESTING
Information Patent Application
DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
- Publication number 20190194191
- Publication date Jun 27, 2019
- Novira Therapeutics, Inc.
- George D. Hartman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
- Publication number 20190077800
- Publication date Mar 14, 2019
- Novira Therapeutics, Inc.
- George D. Hartman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Derivatives And Methods Of Treating Hepatitis B Infections
- Publication number 20190031653
- Publication date Jan 31, 2019
- Novira Therapeutics, Inc.
- George D. Hartman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Scott Kuduk

Person

Patents Grantslast 30 patents

Substituted aminopyridine compounds as EGFR inhibitors

Substituted aminopyridine compounds as EGFR inhibitors

Dihydroorotate dehydrogenase inhibitors

Dihydroorotate dehydrogenase inhibitors

Oxadiazepinone derivatives and methods of treating hepatitis B infe...

Diazepinone derivatives and their use in the treatment of hepatitis...

Derivatives and methods of treating hepatitis B infections

Derivatives and methods of treating hepatitis B infections

Azocane and azonane derivatives and methods of treating hepatitis B...

Derivatives and methods of treating hepatitis B infections

Fused heteroaryl derivatives as orexin receptor antagonists

Oxazole orexin receptor antagonists

Azepane derivatives and methods of treating hepatitis B infections

Piperidine oxadiazole and thiadiazole orexin receptor antagonists

Heteroaryl orexin receptor antagonists

Pyrazole orexin receptor antagonists

Hydroxmethyl piperidine orexin receptor antagonists

Derivatives and methods of treating hepatitis B infections

Amidoethyl azole orexin receptor antagonists

Pyrrolidine orexin receptor antagonists

Derivatives and methods of treating hepatitis B infections

Derivatives and methods of treating hepatitis B infections

Piperidine isoxazole and isothiazole orexin receptor antagonists

Pyrazole, triazole and tetrazole orexin receptor antagonists

Ethyldiamine orexin receptor antagonists

Methyl diazepane orexin receptor antagonists

Bridged diazepane orexin receptor antagonists

5,5-bicyclic oxazole orexin receptor antagonists

2-pyridyloxy-3-ester-4-ether orexin receptor antagonists

6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists

Patents Applicationslast 30 patents

FUSED HETEROCYCLIC DERIVATIVES

FLUORINATED QUINOLINE, QUINOXALINE AND BENZO[B][1,4]OXAZINE DERIVAT...

BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS

SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS

5-MEMBERED HETEROARYL-CONTAINING AMINOPYRIDINE COMPOUNDS AS EGFR IN...

SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS

FLUORINATED QUINOLINE AND QUINOXALINE DERIVATIVES AS DIHYDROOROTATE...

FUSED HETEROCYCLIC DERIVATIVES

FUSED HETEROCYCLIC DERIVATIVES AS ANTIVIRAL AGENTS

SUBSTITUTED UREA DIHYDROOROTATE DEHYDROGENASE INHIBITORS

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

AZEPINES AS HBV CAPSID ASSEMBLY MODULATORS

FUSED HETEROCYCLE DERIVATIVES

DI-FLUORO AZEPANES AS HBV CAPSID ASSEMBLY MODULATORS

DIAZEPINONE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS

FUSED HETEROCYCLE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS

ISOXAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH H...

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

PYRIMIDONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV IN...

OXADIAZEPINONE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFE...

DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS...

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

OXADIAZEPINONE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFE...

Derivatives And Methods Of Treating Hepatitis B Infections

DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS...

METABOLIC RESTRICTION IN CELL-BASED ASSAYS

DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Derivatives And Methods Of Treating Hepatitis B Infections